Expert Ratings for Rallybio
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have published their opinion on Rallybio (NASDAQ:RLYB) stock, with two giving bullish ratings and two somewhat bullish. The average 12-month price target for Rallybio is $16.25, a decrease of 4.41% from the previous average price target of $17.00.
November 10, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Rallybio has received mixed ratings from analysts, with an average 12-month price target of $16.25.
The mixed ratings from analysts indicate uncertainty about the stock's performance. The decrease in the average price target could potentially impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100